No abstract available
Publication types
-
Case Reports
-
Comparative Study
MeSH terms
-
Adult
-
Antineoplastic Agents / therapeutic use
-
Benzamides
-
DNA, Neoplasm / genetics
-
Disease Progression
-
Female
-
Follow-Up Studies
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Hypereosinophilic Syndrome / drug therapy
-
Hypereosinophilic Syndrome / etiology*
-
Hypereosinophilic Syndrome / genetics
-
Imatinib Mesylate
-
Karyotyping
-
Male
-
Myeloproliferative Disorders / complications
-
Myeloproliferative Disorders / drug therapy
-
Myeloproliferative Disorders / genetics*
-
Oncogene Proteins, Fusion
-
Piperazines / therapeutic use
-
Point Mutation
-
Pyrimidines / therapeutic use
-
Receptor, Platelet-Derived Growth Factor alpha / genetics*
-
Reverse Transcriptase Polymerase Chain Reaction
-
mRNA Cleavage and Polyadenylation Factors / genetics*
Substances
-
Antineoplastic Agents
-
Benzamides
-
DNA, Neoplasm
-
Oncogene Proteins, Fusion
-
Piperazines
-
Pyrimidines
-
mRNA Cleavage and Polyadenylation Factors
-
Imatinib Mesylate
-
FIP1L1-PDGFRA fusion protein, human
-
Receptor, Platelet-Derived Growth Factor alpha